PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release

Detalhes bibliográficos
Autor(a) principal: Andressa Maria Pironi
Data de Publicação: 2023
Outros Autores: Josimar de Oliveira Eloy, Camila Fernanda Rodero, Selma Gutierrez Antonio, Jovan Duran Alonso, Marlus Chorilli
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/211846
Resumo: Solid dispersions (SDs) of ursolic acid (UA) were developed using polyvinylpyrrolidone K30 (PVP K30) in combination with non-ionic surfactants, such as D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) or poloxamer 407 (P407) with the aim of enhancing solubility and in vitro release of the UA. SDs were investigated using a 24 full factorial design, subsequently the selected formulations were characterized for water solubility, X-ray diffractometry (XRD), differential scanning calorimetry (DSC), particle diameter, scanning electron microscopy, drug content, physical-chemical stability and in vitro release profile. SDs showed higher UA water-solubility than physical mixtures (PMs), which was attributed by transition of the drug from crystalline to amorphous or molecular state in the SDs, as indicated by XRD and DSC analyses. SD1 (with P407) and SD2 (with TPGS) were chosen for further investigation because they had higher drug load. SD1 proved to be more stable than SD2, revealing that P407 contributed to ensure the stability of the UA. Furthermore, SD1 and SD2 increased UA release by diffusion and swelling-controlled transport, following the Weibull model. Thus, solid dispersions obtained with PVP k-30 and P407 proved to be advantageous to enhance aqueous solubility and stability of UA.
id USP-31_63fafb536140f466dfad17e6b90e4b01
oai_identifier_str oai:revistas.usp.br:article/211846
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid releaseUrsolic acidSolid dispersionsSolvent methodWater-solubilitySolid dispersions (SDs) of ursolic acid (UA) were developed using polyvinylpyrrolidone K30 (PVP K30) in combination with non-ionic surfactants, such as D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) or poloxamer 407 (P407) with the aim of enhancing solubility and in vitro release of the UA. SDs were investigated using a 24 full factorial design, subsequently the selected formulations were characterized for water solubility, X-ray diffractometry (XRD), differential scanning calorimetry (DSC), particle diameter, scanning electron microscopy, drug content, physical-chemical stability and in vitro release profile. SDs showed higher UA water-solubility than physical mixtures (PMs), which was attributed by transition of the drug from crystalline to amorphous or molecular state in the SDs, as indicated by XRD and DSC analyses. SD1 (with P407) and SD2 (with TPGS) were chosen for further investigation because they had higher drug load. SD1 proved to be more stable than SD2, revealing that P407 contributed to ensure the stability of the UA. Furthermore, SD1 and SD2 increased UA release by diffusion and swelling-controlled transport, following the Weibull model. Thus, solid dispersions obtained with PVP k-30 and P407 proved to be advantageous to enhance aqueous solubility and stability of UA.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2023-04-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/21184610.1590/s2175-97902023e21217Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21217Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e21217Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e212172175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/211846/194563https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessAndressa Maria PironiJosimar de Oliveira EloyCamila Fernanda RoderoSelma Gutierrez AntonioJovan Duran AlonsoMarlus Chorilli2023-05-29T20:20:21Zoai:revistas.usp.br:article/211846Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-05-29T20:20:21Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release
title PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release
spellingShingle PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release
Andressa Maria Pironi
Ursolic acid
Solid dispersions
Solvent method
Water-solubility
title_short PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release
title_full PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release
title_fullStr PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release
title_full_unstemmed PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release
title_sort PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release
author Andressa Maria Pironi
author_facet Andressa Maria Pironi
Josimar de Oliveira Eloy
Camila Fernanda Rodero
Selma Gutierrez Antonio
Jovan Duran Alonso
Marlus Chorilli
author_role author
author2 Josimar de Oliveira Eloy
Camila Fernanda Rodero
Selma Gutierrez Antonio
Jovan Duran Alonso
Marlus Chorilli
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Andressa Maria Pironi
Josimar de Oliveira Eloy
Camila Fernanda Rodero
Selma Gutierrez Antonio
Jovan Duran Alonso
Marlus Chorilli
dc.subject.por.fl_str_mv Ursolic acid
Solid dispersions
Solvent method
Water-solubility
topic Ursolic acid
Solid dispersions
Solvent method
Water-solubility
description Solid dispersions (SDs) of ursolic acid (UA) were developed using polyvinylpyrrolidone K30 (PVP K30) in combination with non-ionic surfactants, such as D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) or poloxamer 407 (P407) with the aim of enhancing solubility and in vitro release of the UA. SDs were investigated using a 24 full factorial design, subsequently the selected formulations were characterized for water solubility, X-ray diffractometry (XRD), differential scanning calorimetry (DSC), particle diameter, scanning electron microscopy, drug content, physical-chemical stability and in vitro release profile. SDs showed higher UA water-solubility than physical mixtures (PMs), which was attributed by transition of the drug from crystalline to amorphous or molecular state in the SDs, as indicated by XRD and DSC analyses. SD1 (with P407) and SD2 (with TPGS) were chosen for further investigation because they had higher drug load. SD1 proved to be more stable than SD2, revealing that P407 contributed to ensure the stability of the UA. Furthermore, SD1 and SD2 increased UA release by diffusion and swelling-controlled transport, following the Weibull model. Thus, solid dispersions obtained with PVP k-30 and P407 proved to be advantageous to enhance aqueous solubility and stability of UA.
publishDate 2023
dc.date.none.fl_str_mv 2023-04-14
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/211846
10.1590/s2175-97902023e21217
url https://www.revistas.usp.br/bjps/article/view/211846
identifier_str_mv 10.1590/s2175-97902023e21217
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/211846/194563
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21217
Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e21217
Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21217
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222918029869056